Trevena

IPO

Trevena, Inc.

Public · King of Prussia, United States · Founded 2007 · $95.0M raised

Employees
51–200
Founded
2007
Business Model
B2B
Total Funding
$95.0M
Last Round
$60.0M Series CJul 2010
Rounds
2
Type
Public

About

Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with central nervous system (CNS) disorders. The company's novel pipeline is based on Nobel Prize winning research and includes four novel and differentiated drug development programs. OLINVYK is approved by the FDA. Investigational candidates include TRV250 for the acute treatment of migraine, TRV734 for maintenance treatment of opioid use disorder, and TRV045, a novel S1P receptor modulator that may offer a non-opioid approach to treating diabetic neuropathic pain, epilepsy, and other CNS disorders.

Summary

Trevena is a Biotech company based in King of Prussia, United States, founded in 2007. It has raised $95.0M in total across 2 rounds, most recently a $60.0M Series C round in Jul 2010. Investors include Polaris Partners.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOFeb 2014
$64.8M

Sign up to see all 3 rounds

Series C through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trevena on Indexed.vc
<a href="https://indexed.vc/companies/trevena"><img src="https://indexed.vc/api/badge/company/trevena" alt="Trevena on Indexed.vc" width="260" height="76" /></a>